Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Podcast: The Long Run with Luke TimmermanPublished On: Mon Apr 24 2023
Description: Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.
The note was deleted
The note was saved
Your message was sent